Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Cancer tests in Glasgow promise more clinical trials

Cancer tests in Glasgow promise more clinical trials



  lab tests Copyright
Get these images

Caption images

Available tests have been developed for use in routine healthcare

A variety of tests developed in Scotland may help to investigate cancer and see more patients admitted to clinical trials.

Glasgow Cancer Tests is a new set of tests developed at the Glasgow Precision Oncology Laboratory (GPOL).

Available solid tumor and blood cancer tests are intended to be used in routine healthcare, such as in the NHS, worldwide.

They could open up the latest treatments for cancer patients.

And they could also help scientists find out what makes cancer resistant to chemotherapy drugs.

Andrew Biankin, Professor of Surgery at the University of Glasgow and Director of (GPOL), says: "Glasgow Cancer Tests are designed to give every cancer patient access to the latest treatments and clinical "

" Our team of inventors, including Susie Cook, Philip Beer and David Chang, have devoted the last five years of their lives to creating the cancer test in Glasgow. "

Genetic Code

It goes on:" This test will enable patients around the world to receive the best treatments for their cancer. "

Tests analyze the genetic code of a patient's cancer sample to look for biological markers that could show which trial drugs would work and which ones didn't ̵

1; and how the cancer developed in the first place.

Image co pyright
Getty Images

Image caption

The tests are currently being used in a study led by the University of Glasgow for pancreatic cancer patients

They are currently evaluated by NHS laboratories in England and Scotland while also being used in a clinical trial program run by the University of Glasgow, Precision-Panc for pancreatic cancer patients.

Dr. Susie Cook, Head of Medical Genomics at GPOL, said: "The challenge is to clarify how to extract the maximum amount of information about a cancer sample from a small, accessible assay and a small amount of test material.

"It is vital that you have a test that provides what the patient and the doctor need in the real world, rather than one that has requirements that are unlikely to be met in day-to-day healthcare.

"The test should also cover the full range of information available in DNA cancer in order to explore each option for each patient.

" We want to make it very easy for many patients to get involved in clinical trials and companies to they do more research and offer more testing options to patients.

"Glasgow c cancer tests allow this."


Source link